Transforming molecular testing
through pioneering direct-to-PCR technologies

Learn About The Technology

Welcome to Transformative Biotech. We are a startup biotechnology company focused on deploying rapid, highly accurate, robust, direct-to-PCR technologies with the power to transform molecular testing for infectious diseases and cancer.

We are seeking commercialization partners who are in a position to benefit from deploying these disruptive direct-to-PCR technologies.

pcr test

We are seeking commercialization partners who are looking to deploy this disruptive PCR technology.

We are looking for commercialization partners who share our belief in the transformative potential of this technology. Our partners will find themselves at the forefront of a new and exciting era in PCR, providing customers with game-changing solutions that offer unprecedented speed, precision, and sensitivity.

We welcome any interested parties to contact us for further information on how we can work together to bring this innovative technology to market. With a proven track record of innovation and a deep commitment to excellence, we are confident in our ability to deliver a high-quality, reliable product that can transform the way researchers and scientists approach PCR. Join us in this exciting journey and experience the transformative potential of our next-generation PCR technology first-hand.

  • Create dramatic cost savings through direct-to-PCR testing for infectious pathogens, including viruses and bacteria;
  • Offer the ability to collect different sample types, such as nasal swab or saliva samples, and test for infectious pathogens, such as viruses or bacteria;
  • Enable molecular diagnostic testing for infectious pathogens in at-home or doctors’ office/point-of-care settings;
  • Test for more than one pathogen in one sample with multiplex capability;
  • Enable determination of viral load in swab or saliva samples, empowering physicians to treat patients more effectively.
Learn More

IMPORTANT

Industry News